15 Every Hour - StopAfib.org - 15 second
Read MoreStopAfib.org Blog
FDA Warning: Pradaxa Should Not Be Used by Atrial Fibrillation Patients with Mechanical Heart Valves
Good to see the FDA moving on this as we're starting to hear of afib patients with mechanical heart valves getting Pradaxa. Here is the FDA announcement... ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be used …
Read MoreStopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Articles of 2012. There were many topics of interest this year to the atrial fibrillation patient community. As always, the top interest was atrial fibrillation stroke prevention — that included the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for anticoagulants, the HAS-BLED tool …
Read MoreStopAfib.org has joined the Fair Access to Cardiac Technology (FACT) Alliance to raise awareness of the importance of access to this medical technology for the detection of atrial fibrillation and other arrhythmias. The FACT Alliance has started a petition to ensure that everyone has access to this potentially life-saving Mobile Cardiac Telemetry (MCT) technology. Learn …
Read MorePatients with atrial fibrillation are at higher risk of suffering stroke and other complications related to the development of blood clots in their heart. Until 2010, the only oral anticoagulant (blood thinner) to prevent strokes in Afib was warfarin (Coumadin®). Now there are two new oral anticoagulants available in the United States--dabigatran (Pradaxa®) and rivaroxaban …
Read MoreIn December of 2012, the American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts will be sponsoring three Living with Atrial Fibrillation programs in Dallas, Houston, and Tampa. Learn more at: American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts are sponsoring Living with Atrial Fibrillation programs
Read MoreThe Alliance for Aging Research and the AFib Optimal Treatment Task Force have released a new survey that found that atrial fibrillation patients are active in the decision-making process regarding their treatment. Learn more and access the survey reports at: Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in …
Read MoreRecently, StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to ask questions of three of their atrial fibrillation experts, Dr. Walid Saliba, Dr. Sergio Pinski, and Dr. David Van Wagoner, along with StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts from the Cleveland …
Read MoreTommy Morrison, who is participating in the IRONMAN Florida on November 3, is an afib survivor and is raising funds to raise awareness of the devastation that atrial fibrillation causes. We are very honored by his efforts to help us in this mission. Learn more at: IRONMAN triathlete raises awareness of atrial fibrillation and how …
Read MoreAction for Stroke Prevention, an alliance of renowned health experts and patient organizations, has published new reports calling for policy makers and the medical and patient communities to join forces to prevent atrial fibrillation-related strokes. Learn more at: New Report Confirms Europe is on the Brink of a Stroke Crisis
Read More